Abstract:The lgtB gene encoding a beta-1,4-galactosyltransferase gene and the lgtC gene encoding an alpha-1,4-galactosyltransferase from the bacterial pathogen Neisseria meningitidis were cloned into an expression vector and overexpressed in Escherichia coli. Both genes expressed very well, but problems with C-terminal proteolysis were encountered with both proteins. The lgtC protein was initially isolated from extracts of recombinant E.coli as a truncated species that retained enzymatic activity, and was subsequently shown by mass spectrometry to be 19 residues shorter than the expected protein. A specific set of engineered C-terminal deletions was constructed to investigate their effect on the expression of lgtC. As many as 28 residues could be deleted with little effect on activity, and with the concomitant improvement of the overall expression up to fivefold over the full length protein. The lgtB protein was also proteolysed in extracts of normal E.coli strains into enzymatically inactive fragments lacking 28 or 41 C-terminal residues. This degradation could be prevented by expression in an ompT protease deficient strain of E.coli. The full length lgtB protein was not stable in soluble protein extracts from all recombinant strains, however a stable enzyme preparation could be achieved with the membrane fraction from cells of the ompT deficient strain expressing lgtB. Specific deletions of lgtB were also constructed, and 15 residues could be removed without loss of enzyme activity and also with the concomitant improvement of the overall expression up to twofold over the full length protein. Longer deletions produced protein but activity could not be detected in these recombinant strains. Examination of the glycosyltransferase sequences from a wide range of bacteria showed their C-terminal segments of approximately 50 amino acids frequently contained paired basic residues. Engineering of these segments may therefore be required as a general practice to produce these enzymes for use in the large scale chemi-enzymatic synthesis of carbohydrate-based therapeutics.

B4GALT5-deficient CHO-Lec2 cells expressing human alpha1,4-galactosyltransferase: a glycoengineered cell model for studying Shiga toxin receptors

Directed Expression of Halophilic and Acidophilic Β-Glucosidases by Introducing Homologous Constitutive Expression Cassettes in Marine Aspergillus Niger.

Overexpression and topology of bacterial oligosaccharyltransferase PglB.

Gb3 trisaccharide-bearing exosomes as a novel neutralizer for Shiga toxin type 1

Expression of Human Alpha-Galactosidase Leads to Reduction of Major Xenoepitope Gal Alpha(1,3) Gal in Nih 3t3 Cell

Human Alpha Galactosidase and Alpha 1,2 Fucosyltransferase Concordantly Inhibit Xenoreactivity of NIH 3T3 Cells with Human Serum

Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry

Delving into human α1,4-galactosyltransferase acceptor specificity: the role of enzyme dimerization

Molecular Analysis of Three Gain-Of-Function Cho Mutants That Add the Bisecting Glcnac to N-Glycans

Screening Novel Β-Galactosidases from a Sequence-Based Metagenome and Characterization of an Alkaline Β-Galactosidase for the Enzymatic Synthesis of Galactooligosaccharides

Cloning and expression of a novel α-galactosidase from Lactobacillus amylolyticus L6 with hydrolytic and transgalactosyl properties

Screening, cloning and expression of β-galactosidase from lactic acid bacteria and semi-rational design for the improvement of transgalactosylation activity

Cloning, Heterologous Expression, and Characterization of Novel Protease-Resistant Α-Galactosidase from New Sphingomonas Strain.

Mapping the Transglycosylation Relevant Sites of Cold-Adapted β-d-Galactosidase from Arthrobacter sp. 32cB

Producing Recombinant Therapeutic Glycoproteins with Enhanced Sialylation Using CHO-gmt4 Glycosylation Mutant Cells.

Structural Insights into the Substrate Specificity of Streptococcus pneumoniae β(1,3)-Galactosidase BgaC

Role of paired basic residues in the expression of active recombinant galactosyltransferases from the bacterial pathogen Neisseria meningitidis

Shiga Toxin (Stx)-Binding Glycosphingolipids of Primary Human Renal Cortical Epithelial Cells (pHRCEpiCs) and Stx-Mediated Cytotoxicity

Strategies to improve CHO cell culture performance: Targeted deletion of amino acid catabolism and apoptosis genes paired with growth inhibitor supplementation.

Aberration of Serum and Tissue N-Glycans in Mouse β1,4-GalT1 Y286L Mutant Variants

Crystal structure of glycoside hydrolase family 110 α-galactosidase specific for blood group B antigen